ITGAM and neoplasm: It is known, for instance, that TLR3 activation in host immune cells present in the tumor microenvironment induces the activation of cells, such as tumor-suppressive M1 macrophages or tumor-associated CD11b+Ly6G+ neutrophils, with final tumoricidal outcome [27,28].